Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Isis Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of February 26, 2013 to Seek a Lead Plaintiff Position

NEW YORK, NY -- (Marketwire) -- 02/05/13 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of investors who purchased Isis Pharmaceuticals, Inc. ("Isis" or the "Company") (NASDAQ: ISIS) stock between March 29, 2012 and October 15, 2012.

For more information, click here: http://zlk.9nl.com/isis-pharmaceuticals-isis/.

The complaint alleges that throughout the Class Period Isis issued materially false and misleading statements regarding the safety and efficacy of its drug Kynamro, which was currently under development.

On October 16, 2012, the FDA issued a report noting that abnormal growths developed in 3.1% of patients treated with Kynamro, as compared to only 0.9% of patients who took a placebo, concluding that the development of these growths would need to be studied further. In addition, it was reported that three patients treated with Kynamro died during clinical testing. Upon this news, shares of ISIS declined $2.88 per share.

If you suffered a loss in ISIS you have until February 26, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (877) 363-5972, or visit http://zlk.9nl.com/isis-pharmaceuticals-isis/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Cloud Developer Stories
The old monolithic style of building enterprise applications just isn't cutting it any more. It results in applications and teams both that are complex, inefficient, and inflexible, with considerable communication overhead and long change cycles. Microservices architectures, whi...
Dasher Technologies is committed to being the best technology solution company in the United States by operating with the highest integrity and building lasting relationships with its customers and partners. Since 1982, Dasher Technologies helped public, private and nonprofit org...
SYS-CON Events announced today that Prashanth Chandrasekar GM of Rackspace's DevOps Business Segment joined DevOps Summit Silicon Valley faculty. Chandrasekar's session abstract will be published on Monday. Below please find an exclusive interview with Prashanth Chandrasekar, con...
Achieve continuous delivery of applications by leveraging ElasticBox and Jenkins. In his session at DevOps Summit, Monish Sharma, VP of Customer Success at ElasticBox, will demonstrate how you can achieve the following using ElasticBox and the ElasticBox Jenkins Plugin: Create co...
BlueBox bridge the chasm between development and infrastructure. Hosting providers are taking standardization and automation too far. For many app developers it does nothing but spawn mayhem and more work. They have to figure out how their creations live on a pre-fab infrastructu...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE

Breaking Cloud Computing News

GLEN ELLYN, Ill., Aug. 22, 2014 /PRNewswire/ -- This week Inc. magazine announced its annu...